Covered recipient · General Payments record
ALAN L GASS
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$243,824.11
- Reported across 334 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $25,000.00 | 4 |
| Travel and Lodging | $9,188.04 | 12 |
| Consulting Fee | $3,593.75 | 3 |
| Food and Beverage | $619.13 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $34,580.82 | 23 |
| Abbott Laboratories | $3,593.75 | 3 |
| Cook Medical LLC | $95.52 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.88 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.18 | 1 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $20.57 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.72 | 1 |
| Merck Sharp & Dohme Corporation | $19.33 | 1 |
| Lexicon Pharmaceuticals, Inc. | $15.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $718.75 | 06/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125401845 | CMS |
| Abbott Laboratories | $2,300.00 | 06/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125401847 | CMS |
| Abbott Laboratories | $575.00 | 06/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125401849 | CMS |
| ABIOMED | $2,750.00 | 02/09/2024 | Honoraria | Undisputed | 01/23/2026 | 1142223014 | CMS |
| ABIOMED | $36.39 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142222966 | CMS |
| ABIOMED | $84.84 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142223008 | CMS |
| ABIOMED | $1,150.16 | 03/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142223010 | CMS |
| ABIOMED | $7,200.00 | 03/13/2024 | Honoraria | Undisputed | 01/23/2026 | 1142223016 | CMS |
| ABIOMED | $168.63 | 04/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142222990 | CMS |
| ABIOMED | $356.20 | 04/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142222992 | CMS |
| ABIOMED | $999.16 | 04/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142222994 | CMS |
| ABIOMED | $16.89 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142222998 | CMS |
| ABIOMED | $103.51 | 04/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142223000 | CMS |
| ABIOMED | $7,200.00 | 04/18/2024 | Honoraria | Undisputed | 01/23/2026 | 1142223002 | CMS |
| ABIOMED | $516.06 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142223084 | CMS |
| ABIOMED | $2,738.31 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142223086 | CMS |
| ABIOMED | $278.00 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142223096 | CMS |
| ABIOMED | $7,850.00 | 05/03/2024 | Honoraria | Undisputed | 01/23/2026 | 1142223098 | CMS |
| ABIOMED | $125.87 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142223102 | CMS |
| ABIOMED | $80.54 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142222996 | CMS |
| ABIOMED | $632.00 | 06/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142223004 | CMS |
| ABIOMED | $2.05 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142223038 | CMS |
| ABIOMED | $588.06 | 09/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142223088 | CMS |
| ABIOMED | $1,291.95 | 09/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142223090 | CMS |
| ABIOMED | $366.00 | 09/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142223094 | CMS |
| ABIOMED | $46.20 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142223100 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.80 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117957612 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.08 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117957614 | CMS |
| Cook Medical LLC | $95.52 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118327834 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.72 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101417831 | CMS |
| Lexicon Pharmaceuticals, Inc. | $15.15 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081703299 | CMS |
| Merck Sharp & Dohme LLC | $19.33 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141585080 | CMS |
| Novartis Pharmaceuticals Corporation | $23.18 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086959867 | CMS |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $20.57 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080556437 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.